Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IMVT
#1145
Immunovant, Inc. Common Stock
27.730
0
+3.28%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+3.28%
Monthly Change
+3.47%
6 month change
+44.35%
Year Change
+44.35%
Previous Close
26.850
0
Open
27.730
0
Bid
Ask
Low
27.730
0
High
27.730
0
Volume
113
Markets
US Stock Market
Healthcare
IMVT
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
97.98 M
116.51 M
130.41 M
146.05 M
170.92 M
—
Valuation ratios
Enterprise value
1.17 B
148.14 M
1.65 B
3.98 B
2.21 B
10.88 B
Price to earnings ratio
—
-3.85
-9.07
-16.81
-6.26
-27.08
Price to sales ratio
—
—
251.9
174.98
—
—
Price to cash flow ratio
—
-5.7
-10.14
-20.38
-6.89
-28.79
Price to book ratio
—
1.29
5.27
7.07
3.66
7.52
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.26
0.3
0.52
0.39
0.53
0.64
Return on equity %
0.27
0.33
0.58
0.42
0.58
0.7
Return on invested capital %
-17.4 K
-14.49 K
-24.16 K
-54.73 K
-36.29 K
-9 062.58
Gross margin %
100
—
100
100
—
—
Operating margin %
-38.24 K
—
-2 780.39
-1 033.19
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
38.1 K
—
2 783.85
1 039.51
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
21.79
11.52
9.34
13.7
11.16
48.29
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
—
0.02
0.05
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
0.97
1.53
1.55
2.48
2.52
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
4.5
3.06
4.6
4.71
16.7
Net current asset value per share
—
4.68
3.29
4.82
5.06
17.93
Tangible book value per share
—
4.28
2.95
4.47
4.67
16.65
Working capital per share
—
4.27
2.93
4.47
4.61
16.44
Book value per share
—
4.28
2.95
4.47
4.67
16.65
News
Immunovant stock hits 52-week high at 28.32 USD
Indivior Pharmaceuticals to Report Q4 Earnings: What's in the Cards?
Arcutis Biotherapeutics to Report Q4 Earnings: What's in the Cards?
Recursion Pharmaceuticals to Report Q4 Earnings: What's in the Cards?
IMVT Posts Narrower-Than-Expected Q3 Loss, Pipeline in Focus
Immunovant stock hits all-time high at 27.87 USD
Immunovant, Inc. (IMVT) Q3 2026 Earnings Call Transcript
Immunovant shares jump 7% as Q3 loss narrows, beats estimates
Philip Morris, Biogen, Telenor, and more set to report earnings Friday
Immunovant earnings up next as Graves’ disease optimism builds
Wall Street Analysts Predict a 55.04% Upside in Immunovant (IMVT): Here's What You Should Know
How Much Upside is Left in Immunovant (IMVT)? Wall Street Analysts Think 47.39%